AI PHARMA CONSULTING LIMITED
Opportunity 71/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (69/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
1 year extracted from filed iXBRL accountsFinancials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 |
|---|---|
| Average employees | 200 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 6 persons-with-significant-control
- • 4 officers
- • 1 confirmation-statement
Corporate timeline (23 events)Click to expand
- 2026-02-03📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2026-02-03📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2026-02-03📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-12-19📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-19📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-19📄change-person-secretary-company-with-change-dateofficers · CH03
- 2025-12-18📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-18📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2025-12-18📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-18📄change-person-director-company-with-change-dateofficers · CH01
- 2025-12-18📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2025-04-24📄appoint-person-secretary-company-with-name-dateofficers · AP03
- 2025-04-23➕WRIGHT, Claire appointedsecretary
- 2025-02-24📄accounts-amended-with-accounts-type-micro-entityaccounts · AAMD
- 2025-02-11📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-12-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-12-19📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2024-03-13📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2023-12-19📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-03-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2019-03-13🏢Company incorporatedAs AI PHARMA CONSULTING LIMITED
- 2019-03-13➕ASHTON, Christopher Michael appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 7 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Ms Claire Wright Individual · British · DOB 06/1985 · age 41 | 25–50% | — | 25-50% shares | 14/12/2023 |
Mr Christopher Michael Ashton Individual · British · DOB 11/1980 · age 46 | 25–50% | — | 25-50% shares | 13/03/2019 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · PE postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A. GLORY LTD→ 11699597 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ABBEYGATE REST HOMES LIMITED→ 03097956 · est 1995 · no financials extracted | — | — | — | — | 30y | — | — |
| AC TERRINGTON LODGE LIMITED→ 17058372 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| AESTHETIC CLINICAL TRAINING ACADEMY LIMITED→ 12310087 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| AESTHETIC SKIN CARE CLINIC LIMITED→ 16667518 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AFOLAKE LIMITED→ 15474926 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AGATHIYAR SIDDHA AGAM LTD→ 13035915 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| AGNES&HEALTH LTD→ 15809522 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AHMED & SIANA LIMITED→ 15614419 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AHMED HEALTHCARE SERVICES LIMITED→ 11906935 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| AIBES CARE LTD→ 11504204 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| AJ'S GYM PETERBOROUGH LTD→ 13142236 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.